Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxue Tongluo powder injection in acute cerebral infarction (phase II)
CTR20132036Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huoxue Tongluo in brain infarction, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jan 2014; status: active.
02
Drugs
Huoxue Tongluo
03
Conditions
brain infarction
Beyond the preview
Go deeper on CTR20132036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132036.